Susquehanna International Group, LLP Akero Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$21.45 - $29.34 $208,065 - $284,598	9,700 Added 8.45%	124,500 $3.57 Million
Q2 2024 Aug 15, 2024	SELL	$18.31 - $24.62 $920,992 - $1.24 Million	-50,300 Reduced 30.47%	114,800 $2.69 Million
Q1 2024 May 07, 2024	SELL	$17.76 - $31.18 $8.04 Million - $14.1 Million	-452,600 Reduced 73.27%	165,100 $4.17 Million
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $3.6 Million - $15.9 Million	316,000 Added 104.74%	617,700 $14.4 Million
Q3 2023 Nov 14, 2023	BUY	$41.19 - $52.25 $6.26 Million - $7.94 Million	151,900 Added 101.4%	301,700 $15.3 Million
Q2 2023 Aug 11, 2023	BUY	$36.89 - $56.88 $1.47 Million - $2.26 Million	39,800 Added 36.18%	149,800 $6.99 Million
Q1 2023 May 16, 2023	SELL	$37.27 - $50.24 $182,623 - $246,176	-4,900 Reduced 4.26%	110,000 $4.21 Million
Q4 2022 Feb 14, 2023	SELL	$33.44 - $54.8 $1.7 Million - $2.79 Million	-50,900 Reduced 30.7%	114,900 $6.3 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $1.57 Million - $5.26 Million	154,500 Added 1367.26%	165,800 $5.65 Million
Q2 2022 Aug 15, 2022	SELL	$8.0 - $15.01 $25,600 - $48,032	-3,200 Reduced 22.07%	11,300 $107,000
Q1 2021 May 17, 2021	BUY	$24.04 - $34.19 $122,604 - $174,369	5,100 Added 54.26%	14,500 $421,000
Q3 2020 Nov 16, 2020	BUY	$30.79 - $39.92 $289,426 - $375,248	9,400 New	9,400 $289,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.31B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.